1. Home
  2. Labeler Index
  3. Lydia Co., Ltd
  4. 72988-0016
  5. Label Information: Insadol

FDA Label for Insadol

View Indications, Usage & Precautions

Table of Contents

    1. OTC - ACTIVE INGREDIENT
    2. OTC - PURPOSE
    3. OTC - KEEP OUT OF REACH OF CHILDREN
    4. INDICATIONS & USAGE
    5. WARNINGS
    6. INACTIVE INGREDIENT
    7. DOSAGE & ADMINISTRATION
    8. PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Insadol Product Label

The following document was submitted to the FDA by the labeler of this product Lydia Co., Ltd. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Otc - Purpose



Periodontal disease [Dental caries disease, gingivitis, periodontitis (periodontal periodontitis)]


Otc - Keep Out Of Reach Of Children



Keep out of reach of children


Indications & Usage



■ adult: two tablets once, three times a day before meal

■ as a maintenance dose, one tablet once, three times a day before meal


Warnings



Do not take this medicine if

■ people who are hypersensitive to the drugs and ingredients contained in this medicine

Consult a doctor, dentist, or pharmacist before taking this medicine

■ Patients who are overreacting to substrates of azoic pigment, acetyl salicylic acid or other prostaglandin syncase inhibitors should be careful about the use of this drug ■ Be careful because this drug may interfere with the absorption of cholesterol medicines.

■ Pregnancy and lactation (for pregnant women or wives who are likely to be pregnant, only if the therapeutic benefit exceeds the risk) ■ Since this drug contains yellow 4 (tartrazine), consult a doctor, dentist, or pharmacist before taking it (for that item only)

Immediately stop taking this medicine and consult a doctor or pharmacist if: ■ the drug is administered to patients with asthma or chronic stomatosis or is overreacting to non-steroidal anti-inflammatory drugs, it may cause anaphylaxis or respiratory system to overreact


Inactive Ingredient



magnesium stearate, microcrystalline cellulose, sodium starch glycolate, colloidal silicon dioxide, povidone K30


Dosage & Administration



For oral use only


Package Label.Principal Display Panel



label - label

label - label


* Please review the disclaimer below.